← Back to Clinical Trials
Recruiting NCT07378800

NCT07378800 Fostering Positive Care Interactions in Assisted Living

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07378800
Status Recruiting
Phase —
Sponsor University of Maryland, Baltimore
Condition Dementia
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-02-05
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
FPCI-ALEducation Only (EO)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-02-05 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to improve the quality of staff-resident care interactions particularly among residents living with Alzheimer's disease or related dementias (ADRD ) by testing the Fostering Positive Care Interactions in Assisted Living (FPCI-AL) intervention. This study will be a critical first step in determining the sample size needed to test the efficacy of a practical approach to improving the quality of care interactions for assisted living residents living with ADRD, ultimately enhancing behavioral outcomes such as decreasing behavioral symptoms of distress, reducing resistiveness to care, and optimizing engagement in care tasks.

Eligibility Criteria

Inclusion Criteria: * 55 years of age or older * currently residing in a participating community * Evidence of ADRD based on a score ≤20 on the Saint Louis University Mental Status Examination Exclusion Criteria: * Admitted to the assisted living for short term care

Contact & Investigator

Central Contact

Rachel McPherson, PhD, MA

✉ rachelmcpherson@umaryland.edu

📞 410-706-3689

Frequently Asked Questions

Who can join the NCT07378800 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07378800 currently recruiting?

Yes, NCT07378800 is actively recruiting participants. Contact the research team at rachelmcpherson@umaryland.edu for enrollment information.

Where is the NCT07378800 trial being conducted?

This trial is being conducted at Columbia, United States, Elkton, United States, Taneytown, United States.

Who is sponsoring the NCT07378800 clinical trial?

NCT07378800 is sponsored by University of Maryland, Baltimore. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology